This HTML5 document contains 33 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dcthttp://purl.org/dc/terms/
covidprhttp://ns.inria.fr/covid19/property/
fabiohttp://purl.org/spar/fabio/
dcehttp://purl.org/dc/elements/1.1/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
bibohttp://purl.org/ontology/bibo/
n11https://doi.org/10.1093/jac/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
covidhttp://ns.inria.fr/covid19/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://ns.inria.fr/covid19/PMC7454669#
Subject Item
covid:PMC7454669
rdf:type
schema:ScholarlyArticle bibo:AcademicArticle fabio:ResearchPaper
rdfs:isDefinedBy
covid:dataset-1-2
dct:title
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
dce:creator
Hill, Andrew Garratt, Anna Saeedi, Majid Tirgar Fakheri, Hafez Hedayatizadeh Omran, Akbar Alikhani, Ahmad Levi, Jacob Abbaspour Kasgari, Hamideh Merat, Shahin Davoudi Badabi, Ali Shabani, Amir Moradi, Siavash Babamahmoodi, Farhang Simmons, Bryony Davoudi, Lotfollah Wentzel, Hannah
dct:source
Medline; PMC
dct:abstract
n6:abstract
dct:issued
2020-08-19
bibo:doi
10.1093/jac/dkaa332
bibo:pmid
32812025
dct:license
no-cc
schema:url
n11:dkaa332
covidpr:hasTitle
n6:title
fabio:hasPubMedCentralId
PMC7454669
fabio:hasPubMedId
32812025
schema:publication
J Antimicrob Chemother
covidpr:hasBody
n6:body_text